Literature DB >> 10661778

Heparin-induced thrombocytopenia and thrombosis.

K Ananthasubramaniam1, M Shurafa, A Prasad.   

Abstract

Heparin remains the most commonly used parenteral medication in hospitalized patients. Heparin induced thrombocytopenia (HIT) and heparin induced thrombocytopenia with thrombosis syndrome or the white clot syndrome are important complications of heparin use. This article provides an in-depth review of the etiopathogenesis, clinical manifestations, diagnosis, and management options in patients with HIT. Clinical problems associated with HIT such as antiphospholipid antibody syndrome and venous gangrene are described. The management options of HIT patients during cardiac interventional procedures and coronary surgery as well as recent advances in therapeutic options are summarized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661778     DOI: 10.1053/pcad.2000.0420247

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  Recurrent venous thrombosis following free flap surgery: The role of heparin-induced thrombocytopenia.

Authors:  Andreas Nikolis; Apostolos Christopoulos; Michel Saint-Cyr; Carlos Cordoba; Louis Guertin; Patrick G Harris
Journal:  Can J Plast Surg       Date:  2003

2.  Acute and Chronic Pulmonary Emboli.

Authors:  Peter F. Fedullo; Douglas M. Humber
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

3.  Bivalirudin fails to prevent atrial thrombus development in heparin-induced thrombocytopaenia and thrombosis syndrome.

Authors:  Alexandru Topliceanu; Thomas Breen; Hiren Patel; Neil Yager; Erica Maceira; Mikhail Torosoff
Journal:  BMJ Case Rep       Date:  2018-10-14

4.  Heparin-induced Thrombocytopenia.

Authors:  Marie Gerhard-Herman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.